NO954323L - Heterocykliske derivater - Google Patents
Heterocykliske derivaterInfo
- Publication number
- NO954323L NO954323L NO954323A NO954323A NO954323L NO 954323 L NO954323 L NO 954323L NO 954323 A NO954323 A NO 954323A NO 954323 A NO954323 A NO 954323A NO 954323 L NO954323 L NO 954323L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- alkylcarbamoyl
- carbamoyl
- alkoxycarbonyl
- alkoxy
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000002923 oximes Chemical class 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 150000005215 alkyl ethers Chemical class 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- -1 amino, carbamoyl Chemical group 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940031439 squalene Drugs 0.000 abstract 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Forbindelser med formel (I) hvor R1 er hydrogen eller hydroksy; R2 er hydrogen; eller R1 og R2 er forbundet slik at CR^CR2 er en dobbeltbinding; X er valgt fra -CH2CH2-, -CH=CH-, -C=C-, -CH20-, -OCH2-, -CH2NH-, -NHCH2-, -CH2CO-, -COCH2/ - . CH2S(O)n- og -S(O)nCH2- (hvor n er O, l eller 2); Ar er en ; fenylgruppe som bærer en eller flere substituenter uavhengig av hverandre valgt fra gruppene (l-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (1-6C)alkoksy, (1-6C)alkoksykarbonyl, (1-6C)- alkoksykarbonyl(l-6C)alkyl, (1-6C)alkoksy(l-6C)alkyl, (1- 6C)alkylamino, di-[(1-6C)alkyl]amino, karbamoyl, (1-6C)alkyl- karbamoyl, di-[(1-6C)alkyl]karbamoyl, (1-6C)alkanoyl og deres oksimderivater, og O-(1-6C)alkyletere av nevnte oksimer, (1- GOalkyltio, (1-6C) alkylsulf inyl og (1-6C) alkylsulfonyl når substituert med en eller flere grupper valgt fra (1-6C)- alkoksykarbonyl, (1-6C)alkanoyl og deres oksimderivater, og O- (1-6C)alkyletere av nevnte oksimderivater, (1-6C)alkanoyl- amino, (1-6C)alkanoyloksy, (1-6C)alkanoyloksy(1-6C)alkyl, ¿karbamoyl, N-(1-6C)alkylkarbamoyl, N,N-di[(1-6C)alkyl- 'karbamoyl, amino, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, (1- i 6C)alkoksy, (2-6C)alkenyloksy, (1-6C)alkyltio, (1-6C)alkyl- i sulfinyl, (1-6C)alkylsulfonyl, halogen(1-6C)alkyl, (2-6C)- | alkenyl, (2-6C)alkynyl, fenyl, fenoksy, cyano, nitro, hydroksy l og karboksy; og hvor Ar kan bære ytterligere substituenter; og | deres farmasøytisk akseptable salter som hemmer skvalensyntese og følgelig kan brukes for å senke cholesterolnivået i blod- plasma. Det er også beskrevet fremgangsmåter for fremstilling av forbindelser med formel I så vel som farmasøytiske preparater som inneholder disse forbindelser, og deres anvendelse i medisin.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308842A GB9308842D0 (en) | 1993-04-29 | 1993-04-29 | Heterocyclic derivatives |
| GB939324813A GB9324813D0 (en) | 1993-12-03 | 1993-12-03 | Heterocyclic compounds |
| GB9402127A GB9402127D0 (en) | 1994-02-04 | 1994-02-04 | Heterocyclic derivatives |
| PCT/GB1994/000910 WO1994025459A1 (en) | 1993-04-29 | 1994-04-28 | Heterocyclic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO954323D0 NO954323D0 (no) | 1995-10-27 |
| NO954323L true NO954323L (no) | 1995-12-21 |
Family
ID=27266674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO954323A NO954323L (no) | 1993-04-29 | 1995-10-27 | Heterocykliske derivater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5919793A (no) |
| EP (1) | EP0696284A1 (no) |
| JP (1) | JPH08509488A (no) |
| CN (1) | CN1121718A (no) |
| AU (1) | AU6576494A (no) |
| CA (1) | CA2160795A1 (no) |
| FI (1) | FI955164A0 (no) |
| GB (1) | GB9408473D0 (no) |
| IL (1) | IL109451A0 (no) |
| NO (1) | NO954323L (no) |
| WO (1) | WO1994025459A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737721B1 (fr) * | 1995-08-08 | 1997-09-05 | Roussel Uclaf | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant |
| NZ517788A (en) | 1999-09-28 | 2003-11-28 | Eisai Co Ltd | Quinuclidine compounds and drugs containing the same as the active ingredient |
| WO2002016357A2 (en) | 2000-08-18 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| US6479510B2 (en) | 2000-08-18 | 2002-11-12 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| DE60220997T2 (de) | 2001-03-27 | 2008-03-13 | Eisai R&D Management Co., Ltd. | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält |
| PE20021019A1 (es) | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
| JP2005504059A (ja) * | 2001-08-24 | 2005-02-10 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 疾患を処置するための置換アリール７−アザ［２．２．１］ビシクロヘプタン |
| EP1480977A2 (en) | 2002-02-15 | 2004-12-01 | PHARMACIA & UPJOHN COMPANY | Substituted aryl compounds for treatment of disease |
| TW200305636A (en) * | 2002-04-18 | 2003-11-01 | Merck Patent Gmbh | Polymerisable compounds comprising a cinnamic acid group and an acetylene group |
| US7129268B2 (en) * | 2002-10-28 | 2006-10-31 | Novo Nordisk A/S | Peroxisome proliferator activated receptor-active arylene acetic acid derivatives |
| WO2005105736A1 (en) * | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
| ATE475642T1 (de) * | 2004-05-05 | 2010-08-15 | High Point Pharmaceuticals Llc | Phenoxyessigsäurederivate als ppar-agonisten |
| BRPI0620468A2 (pt) | 2005-12-22 | 2011-11-08 | Transtech Pharma, Inc. | ácidos fenóxi acéticos como ativadores de ppar delta |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| US11267795B2 (en) | 2020-07-22 | 2022-03-08 | Reneo Pharmaceuticals, Inc. | Crystalline PPAR-delta agonist |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0597821A1 (en) * | 1988-04-01 | 1994-05-18 | Sankyo Company Limited | 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics |
| YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
| US5385912A (en) * | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| AU1752792A (en) * | 1991-03-08 | 1992-10-06 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
| GB9201749D0 (en) * | 1992-01-28 | 1992-03-11 | Smithkline Beecham Plc | Medicaments |
| AU3901393A (en) * | 1992-04-10 | 1993-11-18 | Zeneca Limited | Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
| GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
| GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
-
1994
- 1994-04-27 IL IL10945194A patent/IL109451A0/xx unknown
- 1994-04-28 WO PCT/GB1994/000910 patent/WO1994025459A1/en not_active Ceased
- 1994-04-28 AU AU65764/94A patent/AU6576494A/en not_active Abandoned
- 1994-04-28 JP JP6524035A patent/JPH08509488A/ja active Pending
- 1994-04-28 CN CN94191933A patent/CN1121718A/zh active Pending
- 1994-04-28 GB GB9408473A patent/GB9408473D0/en active Pending
- 1994-04-28 CA CA002160795A patent/CA2160795A1/en not_active Abandoned
- 1994-04-28 EP EP94913724A patent/EP0696284A1/en not_active Withdrawn
- 1994-04-28 US US08/537,827 patent/US5919793A/en not_active Expired - Fee Related
-
1995
- 1995-10-27 NO NO954323A patent/NO954323L/no not_active Application Discontinuation
- 1995-10-27 FI FI955164A patent/FI955164A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2160795A1 (en) | 1994-11-10 |
| FI955164A7 (fi) | 1995-10-27 |
| IL109451A0 (en) | 1994-07-31 |
| US5919793A (en) | 1999-07-06 |
| CN1121718A (zh) | 1996-05-01 |
| NO954323D0 (no) | 1995-10-27 |
| JPH08509488A (ja) | 1996-10-08 |
| FI955164A0 (fi) | 1995-10-27 |
| EP0696284A1 (en) | 1996-02-14 |
| AU6576494A (en) | 1994-11-21 |
| GB9408473D0 (en) | 1994-06-22 |
| WO1994025459A1 (en) | 1994-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954323L (no) | Heterocykliske derivater | |
| DE60003001D1 (en) | Pyrimidinverbindungen | |
| GB0206860D0 (en) | Compounds | |
| EP1550662A4 (en) | NEW ADENINE COMPOUND AND ITS USE | |
| AU6307290A (en) | Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same | |
| AU617918B2 (en) | 2-aminopyrimidinone derivatives | |
| AU4257901A (en) | Triarylimidazole derivatives as cytokine inhibitors | |
| EP1400529A4 (en) | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF | |
| AU624405B2 (en) | Heterocyclic bisphosphonic acid derivatives | |
| MXPA03008215A (es) | Inhibidores de integrina alfa v beta 6. | |
| RU2027435C1 (ru) | Вещество, снижающее внутриглазное давление | |
| AU622509B2 (en) | 2-aminopyrimidinone derivatives | |
| NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
| TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
| KR880012586A (ko) | 새로운 피리딜 및 피리미딜 유도체 | |
| DK561487D0 (da) | 4-phenylsulfonyl-3,4-dihydro-2(1h)-quinoxalinon-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse | |
| EP0654032A1 (en) | Quinuclidine derivatives as squalene synthase inhibitors. | |
| EP1136488A4 (en) | SF2809-I, II, III. VI, V AND VI COMPOUNDS WITH CHYMASE INHIBITING EFFECT | |
| CA2140781A1 (en) | Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives | |
| ATE285771T1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
| EP1132085A4 (en) | MEDICINAL PRODUCTS AND REAGENTS CONTAIN THE N-ACYLOXYLATED CYCLOALKYL COMPOUNDS AS ACTIVE INGREDIENTS | |
| NZ512891A (en) | S-oxide lipid lowering compounds | |
| DE69320911D1 (de) | Chinuclidine derivate als squalen synthase inhibitore | |
| EP1219619A4 (en) | piperidine | |
| US5273976A (en) | Ocular hypotensive agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |